Genetic background influences metabolic response to dietary phosphorus restriction

Journal of Nutritional Biochemistry

Volumn 17, Issue 6, 2006, Pages 385-395

  Hittmeier, Laura J ^a   Grapes, Laura ^a   Lensing, Renae L ^a   Rothschild, Max F ^a   Stahl, Chad H ^a  

^a IOWA STATE UNIVERSITY   (United States)

Author keywords

Bone; Gene expression; Osteoporosis; Phosphorous; Pigs

Indexed keywords

CALCITONIN RECEPTOR; INTERLEUKIN 6; OXYTOCIN RECEPTOR; PHOSPHORUS; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TRANSCRIPTION FACTOR IIB; TRANSCRIPTION FACTOR SOX9; VITAMIN D RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE GROWTH; BONE MARROW; BONE STRENGTH; BONE STRUCTURE; CONTROLLED STUDY; DIET RESTRICTION; DIETARY INTAKE; FEMALE; GENE EXPRESSION; GENETIC ANALYSIS; METABOLISM; NONHUMAN; NUCLEOTIDE SEQUENCE; PHOSPHATE DEFICIENCY; PHOSPHATE INTAKE; PROTEIN EXPRESSION; RADIUS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SWINE; WEIGHT GAIN;

ANIMALS; BONE AND BONES; CALCIUM; FEMALE; GENOTYPE; HIGH MOBILITY GROUP PROTEINS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; OSTEOPOROSIS; PHOSPHORUS; PHOSPHORUS, DIETARY; POLYMERASE CHAIN REACTION; RECEPTORS, CALCITONIN; RECEPTORS, CALCITRIOL; RECEPTORS, OXYTOCIN; RNA, MESSENGER; SWINE; TENSILE STRENGTH; TRANSCRIPTION FACTOR TFIIB; TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 33646540747     PISSN: 09552863     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2005.08.008     Document Type: Article

References (59)

1. Kass-Wolff J.H. Calcium in women: healthy bones and much more. J Obstet Gynecol Neonatal Nurs 33 1 (2004) 21-33
2. Pocock N.A., Eisman J.A., Hopper J.L., Yeates M.G., Sambrook P.N., and Eberl S. Genetic determinants of bone mass in adults. A twin study. J Clin Invest 80 3 (1987) 706-710
3. Kelly P.J., Eisman J.A., and Sambrook P.N. Interaction of genetic and environmental influences on peak bone density. Osteoporos Int 1 1 (1990) 56-60
4. Bushe C. Profound hypophosphataemia in patients collapsing after a 'fun run'. BMJ (Clin Res Ed) 292 6524 (1986) 898-899
5. Oberleas D. Phytates. Toxicants occurring naturally in foods (1973), National Academy of Sciences, Washington (DC) 363
6. Johnson M.L., Gong G., Kimberling W., Recker S.M., Kimmel D.B., and Recker R.B. Linkage of a gene causing high bone mass to human chromosome 11 (11q12-13). Am J Hum Genet 60 6 (1997) 1326-1332
7. Devoto M., Shimoya K., Caminis J., Ott J., Tenenhouse A., Whyte M.P., et al. First-stage autosomal genome screen in extended pedigrees suggests genes predisposing to low bone mineral density on chromosomes 1p, 2p and 4q. Eur J Hum Genet 6 2 (1998) 151-157
8. Uitterlinden A.G., Burger H., Huang Q., Yue F., McGuigan F.E., Grant S.F., et al. Relation of alleles of the collagen type Ialpha1 gene to bone density and the risk of osteoporotic fractures in postmenopausal women. N Engl J Med 338 15 (1998) 1016-1021
9. Yamada Y., Ando F., Niino N., and Shimokata H. Transforming growth factor-beta1 gene polymorphism and bone mineral density. JAMA 285 2 (2001) 167-168
10. National Research Council. Nutrient requirements of swine. 10th ed. (1998), National Academy Press, Washington (DC)
11. Bowers Jr. G.N., and McComb R.B. A continuous spectrophotometric method for measuring the activity of serum alkaline phosphatase. Clin Chem 12 2 (1966) 70-89
12. Gomori G. A modification of the colorimetric phosphorous determination for use with the photoelectric colorimeter. J Lab Clin Med 27 (1942) 955-960
13. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 4 (2001) 402-408
14. SAS. SAS for windows (release 8.2) (1999-2001), SAS Inst. Inc, Cary (NC)
15. Han Y.M., Roneker K.R., Pond W.G., and Lei X.G. Adding wheat middlings, microbial phytase, and citric acid to corn-soybean meal diets for growing pigs may replace inorganic phosphorus supplementation. J Anim Sci 76 10 (1998) 2649-2656
16. Stahl C.H., Roneker K.R., Thornton J.R., and Lei X.G. A new phytase expressed in yeast effectively improves the bioavailability of phytate phosphorus to weanling pigs. J Anim Sci 78 3 (2000) 668-674
17. Aliapoulios M.A., Goldhaber P., and Munson P.L. Thyrocalcitonin inhibition of bone resorption induced by parathyroid hormone in tissue culture. Science 151 708 (1966) 330-331
18. Raisz L.G., and Niemann I. Early effects of parathyroid hormone and thyrocalcitonin on bone in organ culture. Nature 214 87 (1967) 486-487
19. Ikegame M., Ejiri S., and Ozawa H. Calcitonin-induced change in serum calcium levels and its relationship to osteoclast morphology and number of calcitonin receptors. Bone 35 1 (2004) 27-33
20. Vertino A.M., Bula C.M., Chen J.R., Almeida M., Han L., Bellido T., et al. Nongenotropic, anti-apoptotic signaling of 1alpha, 25(OH)2-vitamin D3 and analogs through the ligand binding domain (LBD) of the vitamin D receptor (VDR) in osteoblasts and osteocytes: mediation by Src, PI3, and JNK kinases. J Biol Chem 14 (2005) 14130-14137
21. Zanello L.P., and Norman A.W. Rapid modulation of osteoblast ion channel responses by 1alpha,25(OH)2-vitamin D3 requires the presence of a functional vitamin D nuclear receptor. Proc Natl Acad Sci 101 6 (2004) 1589-1594
22. Coloso R.M., King K., Fletcher J.W., Weis P., Werner A., and Ferraris R.P. Dietary P regulates phosphate transporter expression, phosphatase activity, and effluent P partitioning in trout culture. J Comp Physiol (B) 173 6 (2003) 519-530
23. Colston K.W., Perks C.M., Xie S.P., and Holly J.M. Growth inhibition of both MCF-7 and Hs578T human breast cancer cell lines by vitamin D analogues is associated with increased expression of insulin-like growth factor binding protein-3. J Mol Endocrinol 20 1 (1998) 157-162
24. Barry J.B., Leong G.M., Church W.B., Issa L.L., Eisman J.A., and Gardiner E.M. Interactions of SKIP/NCoA-62, TFIIB, and retinoid X receptor with vitamin D receptor helix H10 residues. J Biol Chem 278 10 (2003) 8224-8228
25. Akiyama H., Chaboissier M.C., Martin J.F., Schedl A., and De Crombrugghe B. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev 16 21 (2002) 2813-2828
26. Lefebvre V.R., Huange W., Harley V., Goodfellow P., and De Chrombrugghe B. SOX9 is a potent activator of the chondrocyte-specific enhancer of the Proα1(II) collagen gene. Mol Cell Biol 17 4 (1997) 2336-2346
27. Zhao Q., Eberspaecher H., Lefebvre V., and De Crombrugghe B. Parallel expression of Sox9 and Col2a1 in cells undergoing chondrogenesis. Dev Dyn 209 4 (1997) 377-386
28. Wagner T., Wirth J., Meyer J., Zabel B., Held M., Zimmer J., et al. Autosomal sex reversal and campomelic dysplasia are caused by mutations in and around the SRY-related gene SOX9. Cell 79 6 (1994) 1111-1120
29. Cameron F.J., Hageman R.M., Cooke-Yarborough C., Kwok C., Goodwin L.L., Sillence D.O., et al. A novel germ line mutation in SOX9 causes familial campomelic dysplasia and sex reversal. Hum Mol Genet 5 10 (1996) 1625-1630
30. Yasuda H., Shima N., Nakagawa N., Mochizuki S.I., Yano K., Fujise N., et al. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139 3 (1998) 1329-1337
31. Lacey D.L., Timms E., Tan H.L., Kelley M.J., Dunstan C.R., Burgess T., et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93 2 (1998) 165-176
32. Bucay N., Sarosi I., Dunstan C.R., Morony S., Tarpley J., Capparelli C., et al. Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12 9 (1998) 1260-1268
33. Mizuno A., Amizuka N., Irie K., Murakami A., Fujise N., Kanno T., et al. Severe osteoporosis in mice lacking osteoclastogenesis inhibitory factor/osteoprotegerin. Biochem Biophys Res Commun 247 3 (1998) 610-615
34. Simonet W.S., Lacey D.L., Dunstan C.R., Kelley M., Chang M.S., Luthy R., et al. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89 2 (1997) 309-319
35. Weinreb M., Shinar D., and Rodan G.A. Different pattern of alkaline phosphatase, osteopontin, and osteocalcin expression in developing rat bone visualized by in situ hybridization. J Bone Miner Res 5 8 (1990) 831-842
36. Roach H.I. Why does bone matrix contain non-collagenous proteins? The possible roles of osteocalcin, osteonectin, osteopontin and bone sialoprotein in bone mineralisation and resorption. Cell Biol Int 18 6 (1994) 617-628
37. Ducy P., Desbois C., Boyce B., Pinero G., Story B., Dunstan C., et al. Increased bone formation in osteocalcin-deficient mice. Nature 382 6590 (1996) 448-452
38. Price P.A., and Williamson M.K. Effects of warfarin on bone. Studies on the vitamin K-dependent protein of rat bone. J Biol Chem 256 24 (1981) 12754-12759
39. Boivin G., Morel G., Lian J.B., Anthoine-Terrier C., Dubois P.M., and Meunier P.J. Localization of endogenous osteocalcin in neonatal rat bone and its absence in articular cartilage: effect of warfarin treatment. Virchows Arch, A Pathol Anat Histopathol 417 6 (1990) 505-512
40. Malone J.D., Teitelbaum S.L., Griffin G.L., Senior R.M., and Kahn A.J. Recruitment of osteoclast precursors by purified bone matrix constituents. J Cell Biol 92 1 (1982) 227-230
41. Yin P., Xu Q., and Duan C. Paradoxical actions of endogenous and exogenous insulin-like growth factor-binding protein-5 revealed by RNA interference analysis. J Biol Chem 279 31 (2004) 32660-32666
42. Mulroney S.E., Woda C.B., Halaihel N., Louie B., McDonnell K., Schulkin J., et al. Central control of renal sodium-phosphate (NaPi-2) transporters. Am J Physiol Renal Physiol 286 4 (2004) F647-F652
43. Bouchard G., Durham H., McOsker J., Krause G., Ellersieck M., and Reddy C. Determination of the peak bone mass and whole body composition in Sinclair miniature swine. J Bone Miner Res 10 Suppl (1995) S: 476
44. Mosekilde L., Weisbrode S.E., Safron J.A., Stills H.F., Jankowsky M.L., Ebert D.C., et al. Evaluation of the skeletal effects of combined mild dietary calcium restriction and ovariectomy in Sinclair S-1 minipigs: a pilot study. J Bone Miner Res 8 11 (1993) 1311-1321
45. Newman E., Turner A.S., and Wark J.D. The potential of sheep for the study of osteopenia: current status and comparison with other animal models. Bone 16 4 Suppl (1995) 277S-284S
46. Turner A.S. Animal models of osteoporosis-necessity and limitations. Eur Cell Mater 1 (2001) 66-81
47. Spencer G.R. Animal model: porcine lactational osteoporosis. Am J Pathol 95 (1979) 277-280
48. Institute of Medicine. Dietary reference intakes for calcium, phosphorus, magnesium, vitamin D, and fluoride (1997), National Academy Press, Washington (DC)
49. Moss A., Levy A., Kim I., and Park Y. Use of vitamin and mineral supplements in the United States: current users, types of products, and nutrients. Advance data from vital and health statistics, No. 174 (1989), National Center for Health Statistics, Hyattsville (MD)
50. Heaney R.P., and Nordin B.E. Calcium effects on phosphorus absorption: implications for the prevention and co-therapy of osteoporosis. J Am Coll Nutr 21 3 (2002) 239-244
51. Shapiro R., and Heaney R.P. Co-dependence of calcium and phosphorus for growth and bone development under conditions of varying deficiency. Bone 32 5 (2003) 532-540
52. Raisz L.G., and Niemann I. Effect of phosphate, calcium and magnesium on bone resorption and hormonal responses in tissue culture. Endocrinology 85 3 (1969) 446-452
53. Masi L., Becherini L., Colli E., Gennari L., Mansani R., Falchetti A., et al. Polymorphisms of the calcitonin receptor gene are associated with bone mineral density in postmenopausal Italian women. Biochem Biophys Res Commun 248 1 (1998) 190-195
54. Tsai F.J., Chen W.C., Chen H.Y., and Tsai C.H. The ALUI calcitonin receptor gene polymorphism (TT) is associated with low bone mineral density and susceptibility to osteoporosis in postmenopausal women. Gynecol Obstet Invest 55 2 (2003) 82-87
55. Zhao H.Y., Liu J.M., Ning G., Zhang L.Z., Jiang L., Dai M., et al. Association of calcitonin receptor gene polymorphism with bone mineral density in Shanghai women. Zhongguo Yi Xue Ke Xue Yuan Xue Bao 25 3 (2003) 258-261
56. Grundberg E., Brandstrom H., Ribom E.L., Ljunggren O., Kindmark A., and Mallmin H. A poly adenosine repeat in the human vitamin D receptor gene is associated with bone mineral density in young Swedish women. Calcif Tissue Int 73 5 (2003) 455-462
57. Chen J., Zhang L., Qiu J., Peng H., Deng Z., Wang Y., et al. Studies on the relationship between vitamin D receptor gene polymorphism and osteoporosis in postmenopausal women. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 20 2 (2003) 167-168
58. Yamada Y., Ando F., Niino N., and Shimokata H. Association of polymorphisms of interleukin-6, osteocalcin, and vitamin D receptor genes, alone or in combination, with bone mineral density in community-dwelling Japanese women and men. J Clin Endocrinol Metab 88 7 (2003) 3372-3378
59. Knowlton K.F., Radcliffe J.S., Novak C.L., and Emmerson D.A. Animal management to reduce phosphorus losses to the environment. J Anim Sci 82 (2004) 173-195